The 20th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD) meeting took place as a virtual event on the 11-12 May 2022.
The 2022 IOTOD faculty led an engaging two-day meeting, featuring international field experts speaking on multiple and emerging topics, such as: the changing patient profile, opioid analgesic dependence, opioid substitution therapy, the experience so far with long-acting buprenorphine formulations from the patients’ perspectives, and optimising best approaches to address viral hepatitis in PWIDs.
Faculty
The IOTOD conference partners with internationally-renowned faculty from a variety of backgrounds and specialities.
The faculty includes experts in treatment challenges faced in the COVID-era, opioid analgesia dependence, optimising virology care and much more.
Professor Adrian Dunlop
Director and Senior Staff Specialist Hunter New England Local Health District Drug & Alcohol Clinical Services
Newcastle NSW, Australia
Maurice Dematteis
Head of the Department of Addictions, University Hospital of Grenoble
Grenoble, France
Professor Oscar D’Agnone
Consultant Psychiatrist; and Honorary Professor of the Faculty of Medical and Human Sciences, University of Manchester
Manchester, UK
John Marsden
Professor of Addiction Psychology, Addictions Department, King’s College London
London, UK
Nicholas Lintzeris
Drug and Alcohol Services, South-East Sydney Local Health District
Sydney, Australia
Professor Trish Hafford-Letchfield
Head Of School School of Social Work and Social Policy University of Strathclyde
Glasgow, Scotland
Graham Foster
Professor of Hepatology, Queen Mary's University of London & Consultant, Bart's Health NHS Trust
London, UK
Ashley Brown
Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, and Professor of Practice (Viral Hepatitis), Imperial College London
London, UK
